Tilianin Attenuates Myocardial Ischemia–Reperfusion Injury by Targeting RIP3-Mediated Necroptosis

Ruifang Zheng(China Pharmaceutical University), Ming Xu(UConn Health)
Pharmaceuticals
December 31, 2025
Cited by 3


Related Papers